| |
| |
|
| Insider
Information: |
Doyle William F |
| Relationship: |
|
| City: |
Florham Park |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
672,420 |
|
|
Indirect Shares
|
1,298,392 |
|
|
| Direct
Value |
$12,106,686 |
|
|
|
Indirect Value
|
$10,307,138 |
|
|
| Total
Shares |
1,970,812 |
|
|
| Total
Value |
$22,413,823 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
12
|
|
Stock
price went up :
|
2
|
9
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
3.0
|
| Percentage
Gain/Loss : |
 9.3%
|
1,017.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novocure Ltd |
NVCR |
Executive Chairman, Di... |
2022-08-02 |
551,176 |
2018-08-02 |
481,167 |
Premium* |
|
|
Optinose Inc |
OPTN |
Director |
2017-10-17 |
18,803 |
2018-06-28 |
817,225 |
Premium* |
|
|
Minerva Neurosciences, Inc. |
NERV |
Director |
2019-06-27 |
26,111 |
2018-09-10 |
0 |
Premium* |
|
|
Elanco Animal Health Inc |
ELAN |
|
2024-05-21 |
76,330 |
2022-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
69 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2018-09-10 |
4 |
B |
$9.88 |
$39,520 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2018-09-11 |
4 |
B |
$9.72 |
$38,987 |
D/D |
4,011 |
8,011 |
2.39 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2018-09-13 |
4 |
B |
$10.50 |
$21,000 |
D/D |
2,000 |
10,011 |
2.39 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2018-09-14 |
4 |
B |
$10.50 |
$2,100 |
D/D |
200 |
10,211 |
2.31 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2018-09-17 |
4 |
B |
$10.50 |
$18,900 |
D/D |
1,800 |
12,011 |
2.39 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2018-10-11 |
4 |
B |
$10.00 |
$6,000 |
D/D |
600 |
12,611 |
2.39 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2018-11-20 |
4 |
B |
$8.20 |
$16,400 |
D/D |
2,000 |
14,611 |
2.39 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2018-12-10 |
4 |
B |
$8.00 |
$16,000 |
D/D |
2,000 |
16,611 |
2.39 |
- |
|
| OPTN |
Optinose Inc |
Director |
– • • |
2017-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
18,803 |
18,803 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2018-12-11 |
4 |
B |
$7.95 |
$31,800 |
D/D |
4,000 |
20,611 |
2.39 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2018-12-20 |
4 |
B |
$6.50 |
$13,000 |
D/D |
2,000 |
22,611 |
2.39 |
- |
|
| ELAN |
Elanco Animal Health Inc |
|
– • – |
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,649 |
25,956 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2019-06-27 |
4 |
B |
$5.50 |
$19,250 |
D/D |
3,500 |
26,111 |
2.39 |
- |
|
| ELAN |
Elanco Animal Health Inc |
|
– • – |
2023-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,374 |
46,330 |
0 |
- |
|
| ELAN |
Elanco Animal Health Inc |
|
– • – |
2024-03-08 |
4 |
B |
$16.30 |
$244,500 |
D/D |
15,000 |
61,330 |
0.01 |
% |
|
| ELAN |
Elanco Animal Health Inc |
|
– • – |
2024-05-21 |
4 |
B |
$16.98 |
$254,700 |
D/D |
15,000 |
76,330 |
0.01 |
% |
|
| NVCR |
Novocure Ltd |
Director |
– • – |
2017-06-14 |
4 |
OE |
$3.59 |
$23,328 |
D/D |
6,498 |
91,197 |
0 |
- |
|
| NVCR |
Novocure Ltd |
Executive Chairman |
• • – |
2018-01-22 |
4 |
OE |
$3.59 |
$5,561 |
D/D |
1,549 |
92,746 |
0 |
- |
|
| NVCR |
Novocure Ltd |
Executive Chairman |
• • – |
2018-08-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(187,787) |
438,167 |
0 |
- |
|
| NVCR |
Novocure Ltd |
Executive Chairman |
• • – |
2020-01-17 |
4 |
AS |
$95.00 |
$12,708,815 |
D/D |
(133,777) |
509,465 |
0 |
% |
|
| NVCR |
Novocure Ltd |
Executive Chairman |
• • – |
2020-03-06 |
4 |
S |
$69.53 |
$300,387 |
D/D |
(4,320) |
510,511 |
0 |
% |
|
| NVCR |
Novocure Ltd |
Executive Chairman |
• • – |
2020-02-28 |
4 |
S |
$72.22 |
$281,133 |
D/D |
(3,893) |
514,831 |
0 |
% |
|
| NVCR |
Novocure Ltd |
Executive Chairman |
• • – |
2020-02-27 |
4 |
OE |
$79.45 |
$735,628 |
D/D |
9,259 |
518,724 |
0 |
- |
|
| NVCR |
Novocure Ltd |
Executive Chairman |
• • – |
2022-08-02 |
4 |
S |
$69.66 |
$58,305 |
D/D |
(837) |
551,176 |
0 |
% |
|
| NVCR |
Novocure Ltd |
Executive Chairman |
• • – |
2022-03-08 |
4 |
S |
$70.10 |
$167,189 |
D/D |
(2,385) |
552,013 |
0 |
% |
|
69 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
